Evidence map›Paper›PMID 38352851›Full record

ReviewInternational journal of cardiology. Cardiovascular risk and prevention2024

Device's design and clinical perspectives for resistant hypertension therapy.

Oussama Jami, El Allam Oussama, Zaki Mohammed, Imai Soulaymane, Ben Sahi Ilhaam, Youssef Tijani, Ettahir Aziz

Open access · goldAbstract readReview
In one paragraph

Review in International journal of cardiology. Cardiovascular risk and prevention, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 99% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Oussama JamiMohammed V University in Rabat, High School of Technology in Salé; Materials, Energy and Acoustics Team, Rabat, Morocco.
El Allam OussamaNational High School of Arts and Crafts of Casablanca, Hassan II University of Casablanca, Morocco.
Zaki MohammedMohammed VI University of Health Sciences, Biomedical Engineering Department, Casablanca, Morocco.
Imai SoulaymaneMohammed VI University of Health Sciences, Biomedical Engineering Department, Casablanca, Morocco.
Ben Sahi IlhaamMohammed VI University of Health Sciences, Faculty of Medicine, Casablanca, Morocco.
Youssef TijaniMohammed VI University of Health Sciences, Faculty of Medicine, Casablanca, Morocco.
Ettahir AzizMohammed V University in Rabat, High School of Technology in Salé; Materials, Energy and Acoustics Team, Rabat, Morocco.
Université Mohammed VI des Sciences de la Santé · MAMohammed V University · MAUniversity of Hassan II Casablanca · MA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Hypertension is the leading cause of death in the cardiovascular system. Indeed, untreated hypertension can affect one's general health, but medicine can help hypertensive people reduce their chance of developing high blood pressure. However, secondary hypertension remains an unresolved illness. Areas covered: This review will go through the typical and unusual device-based therapies for resistant hypertension that have arisen in recent years. Further to that, the innovations developed in device-based RH treatment will be covered, as well as the research and studies assessing these novel technologies. Expert opinion: The innovative device-based techniques that target resistant hypertension provide a potential therapy that has been backed by a number of studies and clinical trials, whereas pharmacological non-adherence and increased sympathetic activity are recognized to be the primary causes of resistant hypertension. Nevertheless, some limitations will be critical for the future of these RH systems, with the device's design and larger RCTs playing a significant role in determining whether a position in routine treatment could be warranted.

Indexed as

Clinical trialsDevice-based therapyDevice's designSecondary hypertensionSympathetic nerve activity

Identifiers

PMID38352851
PMCPMC10862014
OpenAlexW4391147724

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.